USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: REGENEREX, LLC
City: LOUISVILLE
State: KY
Zip+4: 40202-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $1,323,163.00 4
STTR Phase II $5,015,114.00 2

Award List:

Stem Cell Graft Engineering to Treat Sickle Cell Disease

Award Year / Program / Phase: 2004 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF LOUISVILLE
Principal Investigator: Suzanne T. Ildstad
Award Amount: $220,500.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Sickle Cell Disease (SCD) is an abnormality of red blood cells (RBC) that affects approximately 72,000 people in the United States, or approximately 1 in every 500 African-Americans. With current therapies, the mortality in the United States is 50 percent by age… More

Stem Cell Graft Engineering to Treat Sickle Cell Disease

Award Year / Program / Phase: 2008 / STTR / Phase II
Agency: HHS
Research Institution: N/A
Principal Investigator:
Award Amount: $1,414,979.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Sickle Cell Disease (SCD) is a genetic abnormality of red blood cells (RBC) that affects over 70,000 people in the United States, or approximately 1 in every 500 African-Americans. With current therapies, the mortality in the United States is 50% by age 40. SCD… More

Induction of Donor Tolerance in Renal Transplants

Award Year / Program / Phase: 2011 / STTR / Phase II
Agency: HHS
Research Institution: UNIVERSITY OF LOUISVILLE
Principal Investigator: Suzanne T. Ildstad – 502-852-2080
Award Amount: $3,600,135.00
RI Contact:
Abstract:
DESCRIPTION: Renal transplantation is the preferred therapeutic approach for end organ failure. However, the chronic use of immunosuppressive agents is critical to prevent rejection. The drugs are costly ( 15,000-25,000/year) and have significant toxicities including opportunistic infection, an… More

Delayed Tolerance Induction in Living Related Donor Renal Transplant Recipients

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF LOUISVILLE
Principal Investigator: Suzanne T. Ildstad – 502-852-2080
Award Amount: $299,662.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): We have developed a protocol that reproducibly induces transplantation tolerance in individuals undergoing a living related donor kidney transplant. Three subjects have been off all immunosuppression for 10 months, 2 months, and 1 month respectively and have… More